EP3411402
BCMA og CD3 tvísértækar T-frumu-tengjandi mótefnissmíðar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
2.2.2017EP published:
22.12.2021EP application number:
17703376.8
EP translation filed:
18.1.2022Grant published:
15.2.2022EPO information:
European Patent Register
Max expiry date:
1.2.2037Expiry date:
1.2.2027Next due date:
28.2.2027
Title in English:
BCMA AND CD3 BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTSLanguage of the patent:
English
Timeline
Today
2.2.2017EP application
22.12.2021EP Publication
18.1.2022Translation submitted
15.2.2022Registration published
1.2.2027Expires
Owner
Name:
Amgen Research (Munich) GmbHAddress:
Staffelseestrasse 2, 81477 München, DE
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks, California 91320-1799, US
Inventor
Name:
RAUM, TobiasAddress:
81477 Munich, DE
Name:
MUENZ, MarkusAddress:
81477 Munich, DE
Name:
BROZY, JohannesAddress:
81477 Munich, DE
Name:
KUFER, PeterAddress:
81477 Munich, DE
Name:
HOFFMANN, PatrickAddress:
81477 Munich, DE
Name:
FRIEDRICH, MatthiasAddress:
81477 Munich, DE
Name:
RATTEL, BennoAddress:
81477 Munich, DE
Name:
BOGNER, PamelaAddress:
81477 Munich, DE
Name:
WOLF, AndreasAddress:
81477 Munich, DE
Name:
POMPE, CorneliusAddress:
81477 Munich, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662290831 PDate:
3.2.2016Country:
US
Classification
Categories:
C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 24.1.2022
Expires: 1.2.2023
Payer: Patice ehf.
Number: 7
Paid: 19.1.2023
Expires: 1.2.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 23.1.2024
Expires: 1.2.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 24.1.2025
Expires: 1.2.2026
Payer: Árnason Faktor ehf.
Number: 10
Paid: 4.2.2026
Expires: 1.2.2027
Payer: Árnason Faktor ehf.